手性化学试剂是指含有一个或多个不对称中心,在分子结构中至少有一个碳原子与四个不同的基团相连的有机化合物。这些不对称中心赋予了化合物旋光活性,导致它们具有左旋和右旋两种形式(即对映体)。在化学反应中,不同构型的手性试剂可以引发立体选择性的反应,从而形成单一立体异构体产物。
手性化学试剂在药物合成、催化过程、分析化学等多个领域都有着广泛的应用。例如,在药物研发过程中,许多活性成分因其具有手性结构而可能产生不同的生物效应,因此需要通过精确控制使用的手性试剂来确保最终产品的纯度和药效。此外,在催化剂的设计中,选择合适的手性配体或辅剂也能够显著提高反应的选择性和效率。
合成手性化学试剂的方法包括但不限于不对称合成、利用天然产物作为起始原料进行衍生化以及采用生物催化手段等。随着研究的深入和技术的发展,人们对于手性分子的认识越来越深刻,这也促进了相关领域的快速发展和进步。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
(11bS)-2,6-双(3,5-二甲基苯基)-4-羟基-4-氧化物-萘并[2,1-d:1'',2''-f][1,3,2]二氧磷 | (R)-3,3'-bis(3,5-dimethylphenyl)-1,1'-binaphthol phosphonate | 1170736-59-0 | C36H29O4P |
|
顺式3,4-二氨基吡咯烷-1-羧酸叔丁酯 | tert-butyl (3S,4R)-3,4-diaminopyrrolidine-1-carboxylate | 945217-60-7 | C9H19N3O2 |
|
顺式-维他命K1 | (2'Z,7'R,11'R)-Phyllochinon | 16033-41-3 | C31H46O2 |
|
氢化奎宁 1,4-(2,3-二氮杂萘)二醚 | (DHQ)<sub>2</sub>PHAL | 140924-50-1 | C48H54N6O4 |
|
右旋樟脑-10-磺酰氯 | (+)-10-camphorsulfonyl chloride | 21286-54-4 | C10H15ClO3S |
|
反-2-庚烯酸 | E-hept-2-enoic acid | 10352-88-2 | C7H12O2 |
|
十氢化-2,6-萘二甲酸二甲酯 | dimethyl decahydronaphthalene-2,6-dicarboxylate | 3068-02-8 | C14H22O4 |
|
亚麻醇 | Linoleyl alcohol | 506-43-4 | C18H34O |
|
S-1-氨基-2-丙醇 | (S)-1-amino-2-propanol | 2799-17-9 | C3H9NO |
|
L-樟脑酸 | (1S,3R)-(-)-camphoric acid | 560-09-8 | C10H16O4 |
|
L-(-)-二苯甲酰酒石酸 | (+/-)-2,3-O-dibenzoyltartaric acid | 2743-38-6 | C18H14O8 |
|
D-(-)-酒石酸二甲酯 | Dimethyl D-tartrate | 608-69-5 | C6H10O6 |
|
D-(+)-二苯甲酰酒石酸一水物 | (+)-dibenzoyl-D-tartaric acid monohydrate | 80822-15-7 | C18H14O8*H2O |
|
4-sec-丁环己胺 | 4-(1-Methylpropyl)-cyclohexylamin | 25834-93-9 | C10H21N |
|
4-(1-金刚烷基)苯酚 | 4-adamantylphenol | 29799-07-3 | C16H20O |
|
3-溴-1-金刚烷甲酸 | 3-bromoadamantane-1-carboxylic acid | 21816-08-0 | C11H15BrO2 |
|
3-七氟丁酰-D-樟脑 | (-)-3-(heptafluorobutyryl)camphor | 51800-99-8 | C14H15F7O2 |
|
3-[[((1R,2R)-2-(1-哌啶基)环己基]氨基]-4-[[4-(三氟甲基)苯基]氨基]-3-环丁烯-1,2-二酮 | 3-((1R,2R)-2-(piperidin-1-yl)cyclohexylamino)-4-(4-(trifluoromethyl)phenylamino)cyclobut-3-ene-1,2-dione | 1211565-08-0 | C22H26F3N3O2 |
|
3,3,3-三氟丙氨酸乙酯盐酸盐 | ethyl 2-amino-3,3,3-trifluoropropanoate hydrochloride | 193140-71-5 | C5H8F3NO2*ClH |
|
2-甲氧基丙酸 | (S)-2-methoxypropanoic acid | 23953-00-6 | C4H8O3 |
|
1-[2-(二甲基氨基)-1-(4-甲氧基苯基)乙基]环己醇 | (R)-venlafaxine | 93413-46-8 | C17H27NO2 |
|
(S,S)-(-)-氢化苯偶姻 | (S,S)-hydrobenzoin | 2325-10-2 | C14H14O2 |
|
(S)-联萘(3,5-二甲苯基)膦 | (R)-xyl-binap | 137219-86-4 | C52H48P2 |
|
(S)-5-氨基-哌啶-2-酮盐酸盐 | (S)-5-aminopiperidin-2-one hydrochloride | 672883-95-3 | C5H10N2O*ClH |
|
(S)-3-氯-1,2-丙二醇 | (S)-3-chloropropan-1,2-diol | 60827-45-4 | C3H7ClO2 |
|
(S)-2-(6-羟基-2,3-二氢苯并呋喃-3-基)乙酸甲酯 | methyl ((3S)-6-hydroxy-2,3-dihydro-1-benzofuran-3-yl)acetate | 1000414-38-9 | C11H12O4 |
|
(S)-1-(4-吡啶基)-1,3-丙二醇 | (-)-(S)-1-(pyridin-4-yl)-1,3-propanediol | 685111-87-9 | C8H11NO2 |
|
(S)-(-)-三氟乳酸 | (S)-trifluorolactic acid | 125995-00-8 | C3H3F3O3 |
|
(S)-(-)-3-3′-双(3,5-双(三氟甲基)苯基)-1,1′-二-2-萘酚 | 3,3'-bis-(3,5-bis-trifluoromethyl-phenyl)-[1,1']binaphthalenyl-2,2'-diol | 756491-54-0 | C36H18F12O2 |
|
(S)-(-)-3,3,3-三氟2,3-环氧丙烷 | (S)-2-trifluoromethyl-oxirane | 130025-34-2 | C3H3F3O |
|
(S)-(-)-1-(4-甲氧基苯)乙胺 | (S)-1-(4-Methoxyphenyl)ethylamine | 41851-59-6 | C9H13NO |
|
(S)-(+)-2-(甲氧基甲基)吡唑烷 | (2S)-2-(methoxymethyl)-1-pyrrolidine | 63126-47-6 | C6H13NO |
|
(S)-(+)-1,2,3,4-四氢-1-萘酚 | (S)-1-tetralol | 53732-47-1 | C10H12O |
|
(R)-3-羟基四氢呋喃对甲苯磺酸酯 | (R)-tetrahydrofuran-3-yl 4-methylbenzenesulfonate | 219823-47-9 | C11H14O4S |
|
(R)-2-甲基丁酸 | (R)-2-methylbutyric acid | 32231-50-8 | C5H10O2 |
|
(R)-1-氯-2-丙醇 | (R)-1-chloro-2-propanol | 19141-39-0 | C3H7ClO |
|
(R)-1-(4-甲基苯基)乙胺 | (R)-4'-methyl-1-phenylethylamine | 4187-38-6 | C9H13N |
|
(R)-(-)-2-庚醇 | (R)-2-heptanol | 6033-24-5 | C7H16O |
|
(R)-(-)-1,3-丁二醇 | (R)-butane-1,3-diol | 6290-03-5 | C4H10O2 |
|
(R)-(+)-2-三氟甲基环氧乙烷 | (2R)-2-(trifluoromethyl)oxirane | 143142-90-9 | C3H3F3O |
|
(6S,7S)-2-氨基-4,5,6,7-四氢-6-(丙基氨基)-7-苯并噻唑醇 | (6S,7S)-2-amino-7-hydroxy-6-(propylamino)-4,5,6,7-tetrahydrobenzothiazole | 1001648-71-0 | C10H17N3OS |
|
(2S,4S)-(+)-戊二醇 | (2S,4S)-pentane-2,4-diol | 72345-23-4 | C5H12O2 |
|
(2,2'-二羟基-1,1'-联萘-3,3'-二基)二硼酸 | 2,2'-dihydroxy-1,1'-binaphthyl-3,3'-diboronic acid | 957111-27-2 | C20H16B2O6 |
|
(1SR,2SR)-2-甲基环丙烷羧酸 | cis-2-Methyl-cyclopropancarbonsaeure | 26510-98-5 | C5H8O2 |
|
(1S,2S,5S)-2-(羟甲基)-5-乙烯基奎宁环 | quincorine | 207129-35-9 | C10H17NO |
|
(1S)-(+)-10-樟脑磺哑嗪 | (1S)-(+)-(10-camphorsulfonyl)-oxaziridine | 104322-63-6 | C10H15NO3S |
|
(1R,5S,6R)-3-氮杂双环[3.1.0]己烷-6-甲醇 | ((1R,5S)-3-azabicyclo[3.1.0]hexan-6-yl)methanol | 827599-22-4 | C6H11NO |
|
(1R)-(-)-10-樟脑磺哑嗪 | (-)-(camphoryl)sulfonyl oxaziridine | 104372-31-8 | C10H15NO3S |
|
(-)-文斯内酯 | (-)-2-azabicyclo[2.2.1]hept-5-en-3-one | 79200-56-9 | C6H7NO |
|
(+)-8,8-二氯樟脑磺哑嗪 | (+)-(8,8-dichlorocamphorylsulfonyl)oxaziridine | 127184-05-8 | C10H13Cl2NO3S |
|